Paul Carlson

Company: FDA

Job title: Principal Investigator

Seminars:

Regulatory Considerations for Microbiome-based Therapeutics 9:00 am

• Overview of investigational new drug protocol requirements • CMC considerations for live biotherapeutic products • CMC considerations for fecal transplant based productsRead more

day: Day Two